Episode # 205 • 03 Jan 2025
Weight Loss Medications & Impact on OSA
How are weight loss medications, like Ozempic, reshaping obstructive sleep apnea care? In this episode of the BackTable ENT podcast, host Dr. Gopi Shah discusses emerging weight loss medications and their impact on obstructive sleep apnea (OSA) with Dr. John Carter, a neurologist and sleep specialist, and Dr. Michael Weber, an otolaryngologist.
Timestamps
00:00 - Introduction
03:06 - Understanding Weight Loss Medications
06:18 - Impact of Weight Loss on OSA
12:56 - Clinical Trials and Research
18:57 - Future of OSA Management
23:19 - Challenges and Considerations
29:27 - Pediatric Considerations
37:05 - Final Thoughts and Contact Information
You may also like
More about this episode
The doctors examine optimal candidates for GLP-1 medications, their side effects, and how these drugs integrate into current OSA treatment pathways. The conversation delves into patients’ experiences, new research findings, and the implications for future sleep apnea management and weight loss strategies. In sum, the episode highlights the promising role of GLP-1 medications while addressing potential challenges and unanswered questions.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.